U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07876024) titled 'Comparative Evaluation of Intranasal Atomized Midazalom Combined With Nitrous Oxide Versus Nitrous Oxide Monotherapy' on Oct. 05.
Brief Summary: The rationale of this trial is to evaluate whether combining intranasal atomized midazolam with nitrous oxide offers better behavior management leading to successful treatment completion in comparison with using nitrous oxide alone. If this combination works well, it can establish a reliable, non-invasive protocol to treat highly anxious and uncooperative pediatric patients safely.
Additionally, studying the mucosal atomization device will confirm if this mist-like delivery reduces the nas...